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Abstract
Background: Different techniques are used for the right ventricular outflow tract reconstruction,
including homo- or porcine xenografts, which have several limitations. Contegra, a bovine jugular
vein graft, is an interesting alternative to overcome these limitations. It consists of a bovine jugular
vein with a naturally integrated valve in it. Isolated pulmonary valve endocarditis is extremely rare.
Case presentation: We report the case of a 20 years old male patient with acute endocarditis
of bovine Contegra valved conduit, four years after right ventricular outflow tract reconstruction
and atrial septal defect correction, associated with acute glomerulonephritis, renal failure and
severe anemia, secondary to methicillin-resistant Staphylococcus aureus infection (MRSA).
Conclusion: We present a complex patient with acute endocarditis of bovine Contegra valved
conduit. We believe that the presentation of this case should encourage the researchers for the
discussing of the implantation of this conduit and the prevention of endocarditis in these patients.
Background
A variety of prosthetic conduits and homografts for the
right ventricular outflow tract reconstruction have been
developed in recent decades. Homografts, which have
been presented as the most reliable option, have shown
early degeneration and calcification, particularly in very
young patients [1], and those failed to be the best choice
in the long term follow-up [2,3]. The recently developed
Contegra® valved bovine conduit (Medtronic Inc., Minne-
apolis, MN, USA) has encouraged short-term success in
experimental animal studies [4,5], as well as in humans
[6,7]. It consists of a bovine jugular vein, which contains
a venous valve with three leaflets that open to allow the
forward flow of blood and close to prevent the backward
flow of blood, and it functions like the patient's natural
pulmonary artery valve.
The Contegra® Pulmonary Valved Conduit can be used in
children and young adults under the age of 18 [8]. Iso-
lated endocarditis of the pulmonary valve is uncommon
and usually occurs in conjunction with tricuspid and/or
left-sided valvular endocarditis [9]. A mortality rate for
Staphylococcus aureus prosthetic valve endocarditis is
very high [10].
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We describe here a case of a 20 years old male patient with
acute endocarditis of bovine Contegra valved conduit,
four years after right ventricular outflow tract reconstruc-
tion and atrial septal defect correction, associated with
acute glomerulonephritis, renal failure and severe anemia,
secondary to methicillin-resistant Staphylococcus aureus
(MRSA) infection.
Case presentation
A 20 years old male patient admitted to our clinic com-
plaining of fever, sweating, fatigue and lost of weight. He
was referred by the secondary health centre in Gjakova,
after ten days hospitalization for suspicious endocarditis.
Four years ago he underwent atrial septal defect correction
and implantation of pulmonary valve with Contegra® Pul-
monary Valved Conduit in Lausanne, Switzerland. A mur-
mur on the precordium was prescribed on his third
month of life. During all his life he was enabled for
enforced physical activity. He periodically complained of
fatigue, dispnea and later on the cyanosis appeared. These
signs and symptoms were aggravated on his age of 15th. At
that time (four years ago) he was diagnosed and success-
fully operated for dysplastic pulmonary valve with its
severe stenosis and severe regurgitation, severe dilatation
of the right ventricle, pulmonary trunk and right pulmo-
nary artery, as well as the type II atrial sepal defect.
On admission the blood pressure was 130/80 mmHg,
pulse rate 100 beats/min., and body temperature 39°C.
Heart auscultation revealed regular heart rhythm, clear
sounds and systolic murmur 5/6 on the precordium with
punctum maximum on the second right intercostal space.
On lung auscultation there was normal findings. ECG
showed normal sinus rhythm, heart rate of 100 beats/
min., and right axis deviation.
Laboratory data showed: high erythrocite sedimentation
(132 mm/h), low number of erythrocites (2.94 × 1012/
mm3); low hemoglobin rate (8 g/dL), low hematocrite
(24%), high number of leucocytes (19.7 × 103/mm3, high
percentage of granylocites (82.7%), high urea (27 mmol/
L) and creatinine (860 mmol/L) concentrations. All other
laboratory findings were within normal reference range.
Blood cultures revealed the MRSA infection.
Chest X-ray showed mild pleural adhesions in right dia-
phragmal localization, and the triangled heart shadow.
The abdominal ultrasonographic examination showed
splenomegaly and signs of diffuse glomerulonephritis.
Transthoracic echocardiography demonstrated the pres-
ence of the huge vegetation on the Contegra bovine leaf-
let, with dimensions 0.56 × 0.75 cm (Fig. 1). Continuous
wave Doppler assessment of the Contegra valve showed
increased pressure gradient (maximal pressure gradient of
80 mmHg, Fig. 2). Tricuspid valve was thickened, with its
important prolapse (Fig. 3). Severe tricuspid regurgita-
tion, high trans-tricuspid pressure gradient (93 mmHg,
Fig. 4) and enlarged right heart chambers (right ventricle
= 5.2 cm, right atrium = 6.9 cm) were registered.
The presence of the huge vegetation on the Contegra bovine  leaflet, with dimensions 0.56 × 0.75 cm, in short-axis par- asternal view of transthoracic echocardiography Figure 1
The presence of the huge vegetation on the Conte-
gra bovine leaflet, with dimensions 0.56 × 0.75 cm, in 
short-axis parasternal view of transthoracic echocar-
diography.
Increased pressure gradient (maximal pressure gradient of 80  mmHg) of the Contegra valve assessed by continuous wave  Doppler in short-axis parasternal view of transthoracic  echocardiography Figure 2
Increased pressure gradient (maximal pressure gra-
dient of 80 mmHg) of the Contegra valve assessed by 
continuous wave Doppler in short-axis parasternal 
view of transthoracic echocardiography.Cases Journal 2009, 2:57 http://www.casesjournal.com/content/2/1/57
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The left atrium (3.6 cm), aortic root (3.1 cm), left ven-
tricular dimensions (end systolic = 5.4 cm, end-systolic =
3.7 cm), thickens (interventricular septum = 0.9 cm, left
ventricular posterior wall = 0.8 cm) and left ventricular
systolic function (shortening function = 31%, ejection
fraction = 59%) were within normal range. It was regis-
tered mild mitral regurgitation through mildly thickened
mitral valve leaflets.
The patient was treated with beta-blockers, salycilates,
antibiotics (Vancomycin and Gentamycin, which was
reduced and stopped, because of renal failure that was
aggravated during the hospitalization). Also, the transfu-
sions with red blood cells were administrated for the ane-
mia correction.
After three weeks of the intensive treatment, the patient
was transferred to the cardiovascular center that per-
formed the operation four years ago, for the re-correction
of the pulmonary artery valve, in general stable condi-
tions.
Discussion
Since introduction in 1999, Contegra® valved bovine con-
duit (Medtronic Inc., Minneapolis, MN, USA), which con-
sists of a bovine jugular vein, is successfully used in
patients for the right ventricular outflow tract reconstruc-
tion in, and it has advantages compared with homo- or
porcine xenografts [6,7].
Right-sided infective endocarditis represents about 5–
10% [11], whereas the pulmonary valve endocarditis is
less than 2% [12] of all cases of endocarditis, and usually
it is accompanied with other congenital heart anomalies.
The results of Contegra bovine conduit in problematic
right ventricular and pulmonary artery are encouraging,
with good long term survival [6,13-15]. Endocarditis of
the Contegra conduit was shown very rare in the follow-
up of these patients. Breyman T, et al. [6], followed-up the
highest number of patients that underwent this correction
(71 patients) and did not register any case with endocar-
ditis, as well as other researchers [13-15].
Shebani S, et al. [16] followed 64 patients operated with
Contegra conduit, and they detected one patient that had
endocarditis early after operation and did not survive. By
our knowledge this is the only case reported as the endo-
carditis of Conegra conduit in pulmonary valve.
We present case of a 20 years old male patient with acute
endocarditis of bovine Contegra valved conduit, four
years after right ventricular outflow tract reconstruction
and atrial septal defect correction, associated with acute
glomerulonephritis, renal failure and severe anemia, sec-
ondary to MRSA infection. We consider that our case is a
complex one, not referred before in the literature.
A major limitation of our case presentation is the lack of
trans-esophageal echocardiography, which we decided to
don't perform, according to the severe general conditions
of the patient in the admission and their improvement
during the hospitalization, that justified our diagnosis
based on trans-thoracic echocardiography.
Thickend tricuspid valved, with its important prolapse, in api- cal four-chamber view of transthoracic echocardiography Figure 3
Thickend tricuspid valved, with its important pro-
lapse, in apical four-chamber view of transthoracic 
echocardiography.
Severe tricuspid regurgitation and important pressure gradi- ent (93 mmHg), assessed by continuous wave Doppler in api- cal four-chamber view of transthoracic echocardiography Figure 4
Severe tricuspid regurgitation and important pres-
sure gradient (93 mmHg), assessed by continuous 
wave Doppler in apical four-chamber view of tran-
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In conclusion, we present a complex patient with acute
endocarditis of bovine Contegra valved conduit, associ-
ated with acute glomerulonephritis, renal failure and
severe anemia, secondary to MRSA infection.
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